Search

everythinglearnresearchcommunity

for

Search:↓

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

Women with PCOS are more likely to suffer from depression, anxiety, and stress.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Acceptance reduces hair loss distress and medical consultations; coping mechanisms increase them.

Inositol was not more effective than a placebo in treating trichotillomania.

Elderly abuse is often by family members, and doctors, especially dermatologists, can spot it by looking for unusual injuries and malnutrition.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Machine learning can predict symptoms and quality of life in chronic skin disease patients using smartphone app data, and shows that app use varies with patient characteristics.

Scalp hair sweating is a significant predictor of hair cortisol levels.

Premature graying of hair significantly harms psychological and social wellbeing.

Physical activity, height, and smoking affect prostate cancer risk.

Effective PCOS treatments require targeting specific signaling pathways.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

People with Down syndrome have a higher risk of skin disorders and need better screening and treatment.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Acne vulgaris is a common skin condition that can cause low self-esteem and depression, and early treatment is important to prevent scarring.

Fluoxetine was not effective in treating hair-pulling disorder in the short term.

Finasteride lowers risk of urinary issues and surgery by over 50% in 4 years.

The transscrotal testosterone patch normalizes hormone levels in men with AIDS and weight loss but does not improve weight, body mass, or quality of life.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Finasteride for hair loss may cause long-lasting side effects like impotence and low libido, but trials lack proper safety reporting.

Finasteride effectively increases hair growth in men with AGA, works better for those over 30, and may cause some side effects.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.